Enjoy complimentary customisation on priority with our Enterprise License!
“The Stem Cell Banking Market is poised to grow by USD 4.61 billion during 2022-2026, accelerating at a CAGR of 8.08% during the forecast period”
Stem Cell Banking Market is the process of procuring precious stem cells from human body, processing and storing them for potential future use in stem cell treatments. Stem cell banks use low temperatures to preserve the biological properties of stem cells, protect them from contamination and degeneration.
Technavio market report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 15 vendors. Furthermore, this report extensively covers the market segmentation by type adult stem cells and umbilical cord blood stem cells and geography North America, Europe, Asia, and ROW . The market report also offers information on several market vendors, including Cordlife Group Ltd., CordVida, Covis Pharma BV, Cryo Stemcell, Cryo-Cell International Inc., Cryoviva Biotech Pvt. Ltd., FUJIFILM Holdings Corp., Global Cord Blood Corp., PerkinElmer Inc., and Plus Therapeutics Inc. among others.
Download Report Sample to Unlock the Stem Cell Banking Market Size for the Forecast Period and Other Important Statistics
Our Technavio Research categorizes the report belonging to Pharmaceuticals & Life Science and with a segment of umbilical cord blood stem cells market. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions.
Technavio is a global technology research and advisory company. We use a proprietary Research Methodology tailored to each market we cover. Unlike most vendors that provide similar reports, our team of Industry Experts constantly validates our data, assumptions, and conclusions based on in-depth research and over 50 years of combined experience in the IT Industry. Our data is completely original: it has not been aggregated or replicated. This creates a unique opportunity for you to obtain a comprehensive view of the current state of the market as well as provide deep insights into future outlook areas.
The stem cell banking market is largely driven by increasing federal investments in stem cell therapy and the growing technological advancements in stem cell banking. However, high operational costs have been cited as a major hindrance to growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the stem cell banking industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Stem Cell Banking Market Driver
One of the key factors driving growth in the stem cell banking market is the increased federal investment in stem cell therapy. Many research institutions and small vendors cannot afford to invest in stem cell therapy-related services, as research and clinical trials of stem cell therapy are expensive. Government organizations have realized the importance and potential of stem cell research and increased their funding for these studies. Many state-oriented organizations also provide funding for stem cell studies. Thus, the rising investments in stem cell research will increase the demand for stem cell banking during the forecast period.
Key Stem Cell Banking Market Challenge
The high operational costs will be a major challenge for the stem cell banking market during the forecast period. These costs cannot be met by patients and act as a barrier to the entry of new vendors into the market. The associated costs are usually more pronounced with private cord blood banks. For example, Private cord blood banking is expensive. You will pay a starting fee of about $1,000 to $2,000, plus a storage fee of more than $100 a year for as long as the blood is stored. Stem cell banking service is also expensive in Europe, which has the greatest number of stem cell banks in the world. The cost of preservation of stem cells is quite high at $2,000-$2,500 for 20 years, which does not include the cost of possible therapies later. Hence, with such high costs, families may not opt for stem cell banking even with the awareness about possible medical benefits. This will affect the growth of the market during the forecast period.
This stem cell banking market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
The parent, global biotechnology market covers products and companies engaged in R&D or production of all types of biotechnology products such as biologics, biosimilars, bio-betters, and biotech reagents. Technavio calculates the global healthcare market size based on combined revenue generated by manufacturers/providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services.
The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading smart room heater market vendors such as
In this report, we have profiled the key players in the irritable bowel syndrome market. The report provides illustrative insights into the scope and scale of operations, product portfolio and revenue earned by these companies operating in the global irritable bowel syndrome market. The report also evaluates this market's current status with respect to leaders, competitors, and potential risks
Our report provides extensive information on the value chain analysis for the stem cell banking market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
39% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for stem cell banking in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.
The presence of a well-developed healthcare system will facilitate the stem cell banking market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
The regional market is expected to recover during the forecast period with the lifting of lockdowns and ongoing COVID-19 vaccination drives. Therefore, companies have been adopting various strategies to cope with the COVID-19 scenario, which include resuming their operations and adapting to the new normal pandemic situation to recover and drive the growth of the market during the forecast period.
To gain further insights on the market contribution of various segments Request a PDF Sample
The stem cell banking market share growth by the adult stem cells segment will be significant during the forecast period. The adult stem cell banking segment leads the market owing to the easy availability of these cells within the human body.
The primary advantages offered by adult stem cells are: Ease of harvesting High acceptance in the human body Effectiveness in tissue regeneration Rapid migration of these cells to the sites of inflammation and triggering the other cells of the immune system, resulting in better healing However, certain disadvantages associated with these cells are hindering their adoption, which includes their limited human leukocyte antigen (HLA) compatibility in procedures such as bone marrow transplantations.
The report provides a near-term to long-term perspective on the trends and forecasts horizon for the anti-venom market. It offers an overview of the key market drivers and restraints, enabling precise identification of key opportunities in each region over the coming years.
India Stem Cell Banking market - The market share is predicted to grow at a CAGR of 37.85% over the period 2014-2019.
|
Stem Cell Banking Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.08% |
|
Market growth 2021-2025 |
$ 4.61 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
7.22 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 39% |
|
Key consumer countries |
US, Canada, Germany, UK, China, and India |
|
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
|
Key companies profiled |
Cordlife Group Ltd., CordVida, Covis Pharma BV, Cryo Stemcell, Cryo-Cell International Inc., Cryoviva Biotech Pvt. Ltd., FUJIFILM Holdings Corp., Global Cord Blood Corp., PerkinElmer Inc., and Plus Therapeutics Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Type
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
